ERS Research Seminars
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Short video Statements
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Courses and events
Characterisation of clinical phenotypes is mandatory for the development of new drugs
N. Roche (Paris, France)
Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Roche (Paris, France). Characterisation of clinical phenotypes is mandatory for the development of new drugs. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
Senotherapies for chronic lung disease